Yuki Otsuka, None;
Akio Oishi, Alcon pharma (R), Bayer Yakuhin, Ltd (R), Novartis Pharma (F), Novartis Pharma (R), Santen Pharmaceutical Co., Ltd (R);
Manabu Miyata, Alcon Pharmaceuticals (R), Santen Pharmaceutical Co., Ltd (R);
Akihito Uji, Alcon Pharmaceuticals (R), CANON ELECTRONICS INC (R), Senju Pharmaceutical Co., Ltd (R);
maho oishi, None;
tomoko hasegawa, None;
Shogo Numa, None;
Akitaka Tsujikawa, Alcon Japan Ltd (F), Alcon Pharmaceuticals (F), Bayer Yakuhin, Ltd (F), CANON ELECTRONICS INC. (F), CHUGAI PHARMACEUTICAL CO., LTD (R), Daiichi-Sankyo Company, Limited (R), HOYA Corporation (F), Janssen Pharmaceutical K.K. (R), Johnson & Johnson Surgical Vision, Inc (R), Kowa Pharmaceutical Co. Ltd. (F), NIDEK CO., LTD (R), Novartis Pharmaceuticals (F), Otsuka Pharmaceutical Co., Ltd (R), Pfizer Inc (F), SANWA KAGAKU KENKYUSHO CO., LTD. (R), Senju Pharmaceutical Co., Ltd (F), TOMEY corporation (F), Wakamoto Pharmaceutical Co.,Ltd (F)